Navigation
Pages
Welcome to ScanBalt Business
Today's Portrait Highlights
Skulle Implants Corporation

Skulle Implant Corporation sales, designs and manufactures one-of-a-kind sandwich designed craniomaxillofacial (CMF) –implants (Glace Implants) that delivers outstanding functionality and aesthetics to improve patients’ quality of life. Glace implant is a unique combination of biostable composite material and dissolving bioactive glass. Biostable glass fiber-reinforced composite is made to provide durable and anatomically formed over-lay structure for the implant. Bioactive and antimicrobial part of Glace implant is tailored bioactive glass, which has been shown clinically to be the superior among many different bioceramic compositions. Glace Implants enhance bone growth. Skulle Implants provides two lines of GLACETM implants: (1) Patient specific, GLACETM Custom Made –implants: Made to measure in any shape, structure or form. Durable yet lightweight regardless of implant size. Which are manufactured according to 3D model made from the patient´s CT-scan; (2) GLACETM standard –implants: Range of 15 different shape and sizes to ensure perfect fit. Product line has cranial implants, orbital floor plates and burr hole covers.
Visit WebsiteBioCon Valley®- Health and Innovation in Germany’s North-East

BioCon Valley® is the initiative for life sciences and health economy of the State of Mecklenburg-Vorpommern, Germany. The region with two strong centres around the university cities of Greifswald and Rostock offers distinct research and development facilities and a lively economic community of sme´s and large businesses, outstanding in industrial and marine biotechnology, personalised and regenerative medicine, animal health and plant breeding. As a German BioRegion BioCon Valley® catalyses the commercialization of modern life sciences in the region by networking science, industry and government.
Visit WebsiteHealthCap

HealthCap is a family of multi stage venture capital funds, investing globally in life sciences. We have raised more than EUR 900 million since 1996 making HealthCap one of the largest specialized providers of venture capital within life sciences in Europe.
Visit Website
country-158013_640
